Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer.
Lee JG, McKinney KQ, Mougeot JL, Bonkovsky HL, Hwang SI. Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer. Proteomics. 2013 Dec; 13(23-24):3554-62.